Senior insider sale
VP, Corp Controller and CAO at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$1.04M
26.31K shares
What this filing means
CALVIN SANDRA plans to sell 26.31K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $1.04M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/14/2026ACC: 0001950047-26-003416
Officer· VP, Corp Controller and CAO
Since Sep 2021
26.31K
Shares to sell
$1.04M
Approx. market value
21.98K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
4/14/2026
15.25KRestricted Stock
Not Applicable
1/31/2025
5.46KRestricted Stock
Not Applicable
1/21/2025
1.26KTotal acquired21.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/14/2026 | Stock Option Exercise Cash | 15.25K | — |
1/31/2025 | Restricted Stock Not Applicable | 5.46K | — |
1/21/2025 | Restricted Stock Not Applicable | 1.26K | — |
| Total | 21.98K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.33K
Market value
$139.2K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
21.98K
Market value
$902.6K
4/14/2026
Total
Units
26.31K
Value
$1.04M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 4.33K | $139.2K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 21.98K | $902.6K | NASDAQ | Planned |
| Total | 26.31K | $1.04M | ||